BioSpace News Archive

Merus N.V., a clinical-stage oncology company developing innovative, full-length multispecific antibodies, announced the appointment of Greg Perry as the Company’s Chief Financial Officer.

Impel Pharmaceuticals announced it will present new real-world data adding to the growing body of evidence supporting Trudhesa® nasal spray as an effective acute therapy for migraine management.

TRACON Pharmaceuticals, Inc. announced that it has commenced court proceedings in Hong Kong and the Cayman Islands to enforce an April 2023 arbitration award against I-Mab for approximately $23.0 million, plus interest.

Sensus Healthcare, Inc. announces its participation in the Maxim Group Virtual Healthcare Conference hosted by M-Vest.

Helocyte, Inc., a subsidiary company of Fortress Biotech, Inc., announced that the National Cancer Institute has awarded a $3.22 million grant to City of Hope for clinical studies of Triplex, a cytomegalovirus vaccine being developed by Helocyte and City of Hope.

Indaptus Therapeutics, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients, announced that CEO Jeffrey A. Meckler will participate in the Maxim Group Virtual Healthcare Conference presented by Maxim Group and hosted by M-Vest.

Daxor Corporation announces the launch of a new service designed to drive faster adoption and provide greater prescriber access to Daxor’s innovative blood volume analysis technology.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that George Dyer, MD was elected to the Company’s Board of Directors at its Annual Meeting of Stockholders held on June 14, 2023.

Taysha Gene Therapies, Inc. announced it will host a virtual R&D Day on Wednesday, June 28, 2023 at 10:00 AM ET to discuss updates on TSHA-120, a self-complimentary intrathecally delivered investigational AAV9 gene therapy in clinical evaluation for GAN, and TSHA-102, a self-complementary intrathecally delivered AAV9 investigational gene transfer therapy in clinical evaluation for Rett syndrome.

AltruBio Inc. announced that the company will be giving an oral presentation on its immune checkpoint enhancer, ALTB-268, as well as feature a poster on ICE ALTB-168 at the 2023 Federation of Clinical Immunology Societies Annual Meeting, which is being held June 20-23, 2023 in Boston, Massachusetts.